Blog

News

Aug 3, 2026

Nexomic Partners with Cancer Research Horizons to advance AI-powered precision oncology

Aug 3, 2026

Nexomic Partners with Cancer Research Horizons to advance AI-powered precision oncology

Aug 3, 2026

Nexomic Partners with Cancer Research Horizons to advance AI-powered precision oncology

Aug 3, 2026

Nexomic and Genomics England Partner to Validate DeepOmic

Aug 3, 2026

Nexomic and Genomics England Partner to Validate DeepOmic

Aug 3, 2026

Nexomic and Genomics England Partner to Validate DeepOmic

Jul 29, 2026

Nexomic and Alpha Clinical Partner to De-Risk Oncology Drug Development

Jul 29, 2026

Nexomic and Alpha Clinical Partner to De-Risk Oncology Drug Development

Jul 29, 2026

Nexomic and Alpha Clinical Partner to De-Risk Oncology Drug Development

May 18, 2026

Nexomic Announces Multi-Year Collaboration with Burjeel Cancer Institute

May 18, 2026

Nexomic Announces Multi-Year Collaboration with Burjeel Cancer Institute

May 18, 2026

Nexomic Announces Multi-Year Collaboration with Burjeel Cancer Institute

©

2026-2027 © Nexomic.com

The Greenway, Block C,
112-114 St Stephen's Green,   
Dublin 2, D02 TD28  
Dublin, Ireland

Pages

Home

Resources

Evidence

Information

About

Privacy Policy

Terms & Conditions

Products

DECODE

DEEP360

DISCOVER (coming soon)

Socials

Instagram

X.com

Blog

News

Aug 3, 2026

Nexomic Partners with Cancer Research Horizons to advance AI-powered precision oncology

Aug 3, 2026

Nexomic Partners with Cancer Research Horizons to advance AI-powered precision oncology

Aug 3, 2026

Nexomic Partners with Cancer Research Horizons to advance AI-powered precision oncology

Aug 3, 2026

Nexomic and Genomics England Partner to Validate DeepOmic

Aug 3, 2026

Nexomic and Genomics England Partner to Validate DeepOmic

Aug 3, 2026

Nexomic and Genomics England Partner to Validate DeepOmic

Jul 29, 2026

Nexomic and Alpha Clinical Partner to De-Risk Oncology Drug Development

Jul 29, 2026

Nexomic and Alpha Clinical Partner to De-Risk Oncology Drug Development

Jul 29, 2026

Nexomic and Alpha Clinical Partner to De-Risk Oncology Drug Development

May 18, 2026

Nexomic Announces Multi-Year Collaboration with Burjeel Cancer Institute

May 18, 2026

Nexomic Announces Multi-Year Collaboration with Burjeel Cancer Institute

May 18, 2026

Nexomic Announces Multi-Year Collaboration with Burjeel Cancer Institute

©

2026-2027 © Nexomic.com

The Greenway, Block C,
112-114 St Stephen's Green,   
Dublin 2, D02 TD28  
Dublin, Ireland

Pages

Home

Resources

Evidence

Information

About

Privacy Policy

Terms & Conditions

Products

DECODE

DEEP360

DISCOVER (coming soon)

Socials

Instagram

X.com

Blog

News

Aug 3, 2026

Nexomic Partners with Cancer Research Horizons to advance AI-powered precision oncology

Aug 3, 2026

Nexomic Partners with Cancer Research Horizons to advance AI-powered precision oncology

Aug 3, 2026

Nexomic Partners with Cancer Research Horizons to advance AI-powered precision oncology

Aug 3, 2026

Nexomic and Genomics England Partner to Validate DeepOmic

Aug 3, 2026

Nexomic and Genomics England Partner to Validate DeepOmic

Aug 3, 2026

Nexomic and Genomics England Partner to Validate DeepOmic

Jul 29, 2026

Nexomic and Alpha Clinical Partner to De-Risk Oncology Drug Development

Jul 29, 2026

Nexomic and Alpha Clinical Partner to De-Risk Oncology Drug Development

Jul 29, 2026

Nexomic and Alpha Clinical Partner to De-Risk Oncology Drug Development

May 18, 2026

Nexomic Announces Multi-Year Collaboration with Burjeel Cancer Institute

May 18, 2026

Nexomic Announces Multi-Year Collaboration with Burjeel Cancer Institute

May 18, 2026

Nexomic Announces Multi-Year Collaboration with Burjeel Cancer Institute

©

The Greenway, Block C,
112-114 St Stephen's Green,   
Dublin 2, D02 TD28  
Dublin, Ireland

Pages

Home

Resources

Evidence

Information

About

Privacy Policy

Terms & Conditions

Products

DECODE

DEEP360

DISCOVER (coming soon)

Socials

Instagram

X.com